Opinion: The rescheduling of medical marijuana could be the start of a broader rescheduling initiative that would affect ...

The move only shifted a certain category of weed.

Announced April 22, 2026, and effective April 28, 2026, the Justice Department (Attorney General) and the Drug Enforcement ...

Three Republican attorneys general are asking a federal appeals court to block the Trump administration's push to reschedule ...

A biopharmaceutical company involved in developing drugs derived from cannabinoids, as well as several doctors and groups ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP explain the approach and significance of the final order rescheduling cannabis from Schedule I to Schedule III of the Controlled ...

Green Thumb is better positioned to benefit from cannabis rescheduling than most cannabis companies.

Forbes contributors publish independent expert analyses and insights. I cover the business of cannabis. For the U.S. legal cannabis industry, 2024 was a mixed bag. Progress was made on rescheduling ...

Tilray Brands is back in focus as analysts reset their thinking on where the stock might be headed, with some firms cutting price targets in both US$ and C$ while others keep their fair value view ...

The proposed rescheduling of cannabis currently under consideration by the Department of Health and Human Services, the Department of Justice and the Drug Enforcement Agency would move it from ...